<?xml version="1.0" encoding="UTF-8"?>
<p>Thus, this review paper comprehensively discussed the various types of sesquiterpenes, active constituents related, and their devoted involvement toward the improvement of cholinergic transmission by inhibiting the AChE. Their involvement in different alternate targets for AD management was also discussed briefly. The described sesquiterpenes are supposed to act as novel compounds for the researchers willing to find some other alternatives than the existing ones for the possible treatment of neurodegenerative diseases, i.e., Alzheimerâ€™s disease.</p>
